Annual report pursuant to Section 13 and 15(d)

TRANSITION PERIOD COMPARATIVE DATA - Schedule of Selected Interim Reporting Financial Information (Details)

v3.24.0.1
TRANSITION PERIOD COMPARATIVE DATA - Schedule of Selected Interim Reporting Financial Information (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
9 Months Ended 12 Months Ended
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Mar. 31, 2022
Mar. 31, 2021
Condensed income statement          
Total revenues from related parties $ 922,569 $ 1,297,429 $ 1,209,968 $ 1,185,204  
Total costs and expenses 888,492 1,244,955 1,179,397 1,158,795  
Loss on impairment (5,187) 0 (5,187) (24,835)  
Gains (losses) on disposal of assets (480) 1,112 (521) 1,347  
Earnings (losses) from unconsolidated affiliates 1,461 7,165 1,136 (1,738)  
Operating income 29,871 60,751 25,999 1,183  
Total other income (expense), net (8,792) (42,739) (6,036) (5,602)  
Income tax expense (7,494) (24,932) (10,754) (11,294)  
Net loss (income) attributable to noncontrolling interests (57) 140 6 (78)  
Net income (loss) attributable to Bristow Group Inc. $ 13,528 $ (6,780) $ 9,215 $ (15,791)  
Earnings (losses) per common share:          
Basic (in dollars per share) $ 0.48 $ (0.24) $ 0.33 $ (0.55)  
Diluted (in dollars per share) $ 0.47 $ (0.24) $ 0.32 $ (0.55)  
Weighted average shares of common stock outstanding:          
Basic (in shares) 28,066 28,139 28,104 28,533  
Diluted (in shares) 28,574 28,139 28,406 28,533  
Condensed cash flows          
Net cash provided by (used in) operating activities $ (13,304) $ 32,037 $ (7,727) $ 123,854  
Net cash used in investing activities (44,142) (47,319) (51,984) (17,370)  
Net cash provided by (used in) financing activities (20,732) 22,035 (24,623) (63,483)  
Effect of exchange rate changes on cash, cash equivalents and restricted cash (24,153) 13,226 (29,445) (8,066)  
Net increase (decrease) in cash, cash equivalents and restricted cash (102,331) 19,979 (113,779) 34,935  
Cash, cash equivalents and restricted cash at beginning of period 266,014 163,683 277,462 231,079  
Cash, cash equivalents and restricted cash at end of period 163,683 183,662 163,683 266,014  
Condensed balance sheets          
Total assets 1,812,001 1,937,278 1,812,001    
Total liabilities 1,025,062 1,114,099 1,025,062    
Total stockholders’ equity $ 786,939 $ 823,179 $ 786,939 $ 835,368 $ 897,071